Oncolytics Biotech (TSE:ONC) Share Price Crosses Below 200 Day Moving Average – Here’s What Happened

Oncolytics Biotech Inc. (TSE:ONC)’s stock price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$14.90 and traded as low as C$14.90. Oncolytics Biotech shares last traded at C$14.90, with a volume of 280 shares.

Oncolytics Biotech Stock Down 1.3%

The stock has a market cap of C$1.50 billion, a price-to-earnings ratio of -40.27 and a beta of 0.80. The firm has a 50 day simple moving average of C$14.90 and a two-hundred day simple moving average of C$14.90. The company has a debt-to-equity ratio of 14.58, a current ratio of 2.88 and a quick ratio of 8.86.

Oncolytics Biotech Company Profile

Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc to co-develop pelareorep, as well as with Roche Holding AG.